Literature DB >> 12614930

Microheterogeneity of anti-myelin-associated glycoprotein antibodies.

Felix Fluri1, Fabrizia Ferracin, Beat Erne, Andreas J Steck.   

Abstract

Antibodies to the myelin-associated glycoprotein (MAG) are implicated in the pathogenesis of an acquired demyelinating polyneuropathy. We studied IgM affinity to MAG in 18 patients with anti-MAG antibodies. Binding of sera was tested for anti-MAG immunoreactivity in central nervous system (CNS) by ELISA and in CNS and peripheral nervous system (PNS) by Western blot analysis. Furthermore, immunohistochemical characterization of IgM binding on sural nerve tissue was investigated using the indirect peroxidase method. Western blot analysis revealed that all sera detected MAG in central myelin, but only eight in peripheral myelin. Anti-MAG-IgM-ELISA-titers correlated significantly (p<0.0001) with PNS-Western blot results. By indirect immunoperoxidase immunohistochemistry, 12 sera stained myelin sheaths, while 6 sera showed no staining. These results demonstrate considerable variations in antibody binding strength to MAG between PNS myelin and CNS myelin. The relevance of these differences for the pathogenesis of the neuropathy and clinical impairment remains to be demonstrated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614930     DOI: 10.1016/s0022-510x(02)00359-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  A case of anti-myelin-associated glycoprotein polyneuropathy and multiple sclerosis: one disease instead of two?

Authors:  Stefano Sotgiu; Alessandra Giua; Maria R Murrighile; Renato Ortu
Journal:  BMJ Case Rep       Date:  2009-02-20

2.  Selective in vivo removal of pathogenic anti-MAG autoantibodies, an antigen-specific treatment option for anti-MAG neuropathy.

Authors:  Ruben Herrendorff; Pascal Hänggi; Hélène Pfister; Fan Yang; Delphine Demeestere; Fabienne Hunziker; Samuel Frey; Nicole Schaeren-Wiemers; Andreas J Steck; Beat Ernst
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-17       Impact factor: 11.205

3.  Case Report: Presence of Anti-MAG in the CSF Can Be Associated With a Neurodegenerative Process With Frontal Involvement.

Authors:  Guillaume Dorcet; Marie Benaiteau; Fabienne Ory-Magne; Antoine Blancher; Jérémie Pariente; Françoise Fortenfant; Chloé Bost
Journal:  Front Neurol       Date:  2022-05-25       Impact factor: 4.086

4.  Anti-MAG IgM: differences in antibody tests and correlation with clinical findings.

Authors:  Sabrina Matà; Stefano Ambrosini; Domenica Saccomanno; Tiziana Biagioli; Marinella Carpo; Aldo Amantini; Fabio Giannini; Alessandro Barilaro; Lucia Toscani; Monica Del Mastio; Giacomo Pietro Comi; Sandro Sorbi
Journal:  Neurol Sci       Date:  2019-10-25       Impact factor: 3.307

5.  Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies.

Authors:  Laurent Magy; Raphaël Kaboré; Stéphane Mathis; Prisca Lebeau; Karima Ghorab; Christiane Caudie; Jean-Michel Vallat
Journal:  J Immunol Res       Date:  2015-05-06       Impact factor: 4.818

6.  Spinal Cord Impairment in Anti-Mag Neuropathy: Evidence from Somatosensory Evoked Potentials.

Authors:  Marilisa Boscarino; Jacopo Lanzone; Lorenzo Ricci; Mario Tombini; Vincenzo Di Lazzaro; Giovanni Assenza
Journal:  Brain Sci       Date:  2020-05-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.